The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | Challenges in understanding and diagnosing ATTR amyloidosis
In this video, Lorena Saelices Gomez, PhD, UT Southwestern Medical Center, Dallas, TX, discusses challenges in understanding transthyretin amyloid (ATTR) fibril structure and the clinical implications of this. Variability in clinical manifestations complicates early diagnosis and assessment of disease progression, and Dr Saelices Gomez emphasizes the need for easy, non-invasive detection tools to improve screening and diagnosis of ATTR amyloidosis. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Honoraria for scientific consulting for Intellia and Attralus
Member of the advisory board of Alexion
